Abstract | AIMS: Bone marrow stromal cells (BMSCs) have been reported to interact with multiple myeloma (MM) and exert a vital function of the survival of MM cells. Heme oxygenase-1 (HO-1), a cytoprotective enzyme, has the potential to become a hematological malignancies targeted gene. This study aimed to investigate the role of HO-1 in MM resistance of BMSCs and its possible mechanisms. MAIN METHODS: In this study, the expression of related proteins was detected by RT-qPCR and Western blot. HO-1 expression was regulated by lentivirus transfection. Cell viability and apoptosis were detected by Flow cytometry and CCK-8. Cytokine secretion was assayed by ELISA. The survival and carcinogenic abilities was detected by clone formation assay. KEY FINDINGS: HO-1 expression in the BMSCs of stage III MM patients was substantially increased, compared with that of healthy donors and stage I/II patients. The results of co-culture of BMSCs and MM cells indicated that, the upregulated HO-1 inhibited the apoptosis of co-cultured MM cells, while downregulated HO-1 promoted the chemosensitivity of co-cultured MM cells, moreover, the upregulated HO-1 in BMSCs increased the colony-formation ability of MM cells. This protective capability may be regulated by CXCL12/CXCR4 signaling. High HO-1 expression in BMSCs can promote the phosphorylation of the JAK2/STAT3 pathway, thereby increasing secretion of SDF-1 in BMSCs and activating CXCL12/CXCR4 signaling. In addition, direct contact between BMSCs and MM cells may cause drug resistance. SIGNIFICANCE: These results indicated that the regulation of HO-1 in BMSCs may be a new effective method of MM therapy.
|
Authors | Jun Huang, Lai-Quan Huang, He-Sheng He, Jiawei Yan, Chen Huang, Ran Wang, Yan Guan, Dong-Ping Huang |
Journal | Life sciences
(Life Sci)
Vol. 257
Pg. 118088
(Sep 15 2020)
ISSN: 1879-0631 [Electronic] Netherlands |
PMID | 32663573
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Elsevier Inc. All rights reserved. |
Chemical References |
- Antineoplastic Agents
- STAT3 Transcription Factor
- STAT3 protein, human
- Heme Oxygenase-1
- JAK2 protein, human
- Janus Kinase 2
|
Topics |
- Aged
- Aged, 80 and over
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(genetics)
- Case-Control Studies
- Coculture Techniques
- Drug Resistance, Neoplasm
- Female
- Heme Oxygenase-1
(genetics)
- Humans
- Janus Kinase 2
(metabolism)
- Male
- Mesenchymal Stem Cells
(cytology)
- Middle Aged
- Multiple Myeloma
(drug therapy, genetics, pathology)
- Neoplasm Staging
- STAT3 Transcription Factor
(metabolism)
|